APA (7th ed.) Citation

Hanna, G. J., Guenette, J. P., Chau, N. G., Sayehli, C. M., Wilhelm, C., Metcalf, R., . . . Ho, A. L. (2020). Tipifarnib in recurrent, metastatic HRAS‐mutant salivary gland cancer. Cancer, 126(17), 3972-3981. https://doi.org/10.1002/cncr.33036

Chicago Style (17th ed.) Citation

Hanna, Glenn J., et al. "Tipifarnib in Recurrent, Metastatic HRAS‐mutant Salivary Gland Cancer." Cancer 126, no. 17 (2020): 3972-3981. https://doi.org/10.1002/cncr.33036.

MLA (9th ed.) Citation

Hanna, Glenn J., et al. "Tipifarnib in Recurrent, Metastatic HRAS‐mutant Salivary Gland Cancer." Cancer, vol. 126, no. 17, 2020, pp. 3972-3981, https://doi.org/10.1002/cncr.33036.